BeStock  
Stocks › Biotechnology › FTRE

Fortrea Holdings FTRE

US equityMarket cap rank #2754Biotechnology
$18.55 −$1.60 (-7.94%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.55 0.00%
Open$19.89
Prev close$20.15
Day range$18.30 – $20.52
Volume1.54M
Market cap$1.79B
P/E (TTM)–
Dividend yield–

Ownership & positioning

Who holds it, who is betting against it, and where the big money is moving

Institutional ownership110.3%+3.60 pts vs. prior quarter
Institutions holding407+16 vs. prior quarter
Insider trades (recent)23 buys / 24 sellsNet selling
Short interest8.88% of floatDays to cover 3.7 · as of 30 Oct 2026
Short-sale volume share24.3%5-day average of daily volume

Short-sale volume as % of daily volume

11%18%25%32%Oct '26Oct '26Nov '26

Large-order net flow, last 20 sessions

Net of large-order buying minus selling, in USD. Over this window: −$726.0K (9 inflow days, 11 outflow days).

Net flow by order size, last 20 sessions

−$5.0MSuper+$4.2MBig−$743.3KMid+$2.2MSmall

Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.

The five largest holders on file together own 38.9% of shares outstanding.

Largest holders

  • BlackRock17.20%
  • The Goldman Sachs Group, Inc.8.58%
  • Sessa Capital IM, L.P.4.76%
  • Vanguard Capital Management, LLC4.32%
  • Vanguard Portfolio Management, LLC4.05%
  • FMR3.94%
  • State Street Global Advisors3.93%
  • Corvex Management LP3.10%

By investor type

  • Mutual Fund74.62%
  • Hedge Fund20.29%
  • Public Company12.17%
  • Government Pension Fund1.44%
  • Individual/Insider1.12%
  • Insurance Company0.79%
  • Private Company0.76%
  • Family Office/Trust0.09%

Reported short interest has fallen from 12.09% to 8.88% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).

Recent institutional activity

HolderTypePeriodShare changeNew stake
Penn Capital Management Company, LLC Mutual Fund 2026/Q3 +1,140,647 1.2%
BlackRock Mutual Fund 2026/Q3 +803,505 17.2%
Invesco Capital Management LLC Mutual Fund 2026/Q3 +776,725 1.5%
Jupiter Fund Management Plc Mutual Fund 2026/Q3 +493,610 0.5%
Dimensional Fund Advisors Mutual Fund 2026/Q3 +356,784 2.1%
First Eagle Investment Management, LLC Mutual Fund 2026/Q3 +305,335 0.3%
JPMorgan Chase & Co. Public Company 2026/Q3 +272,719 0.4%
Nuveen Asset Management LLC Insurance Company 2026/Q3 +263,439 0.7%
Russell Investment Management, LLC Mutual Fund 2026/Q3 +214,955 0.5%
FMR Mutual Fund 2026/Q3 +158,112 3.9%
Anshul Thakral Individual/Insider 2026/Q3 +204,940 0.2%
FMR Mutual Fund 2026/Q3 +2,402,696 3.8%
Wellington Management Group Mutual Fund 2026/Q3 +2,384,349 2.5%
Arrowstreet Capital, Limited Partnership Mutual Fund 2026/Q3 +828,772 0.9%
BlackRock Mutual Fund 2026/Q3 +646,709 16.6%

Institutional buy/sell activity by reporting period, largest moves first.

Insider transactions

DateInsiderTitleTransactionSharesPriceHeld after
10 Sep 2026 Jill McConnell Officer Intent to Sell (Form 144) -1,032 $17.14 –
9 Sep 2026 Jill McConnell Officer Intent to Sell (Form 144) -1,071 $16.53 –
9 Sep 2026 Jason Knoblauch Chief Financial Officer Other Derivative Acquisition +144,434 – 144,434
8 Sep 2026 Jill McConnell Officer Intent to Sell (Form 144) -1,051 $16.85 –
8 Sep 2026 Mark Morais COO & President of Clinical Services Intent to Sell (Form 144) -3,149 $16.85 –
8 Sep 2026 Carrie Russell VP of Accounting & Chief Accounting Officer Intent to Sell (Form 144) -246 $16.85 –
8 Sep 2026 Mark Morais COO & President of Clinical Services Derivative Exercise and Sale -3,149 $16.85 86,419
8 Sep 2026 Carrie Russell VP of Accounting & Chief Accounting Officer Derivative Exercise and Sale -246 $16.85 2,384
7 Sep 2026 Mark Morais COO & President of Clinical Services Derivative Exercise and Retained +4,008 – 86,419
7 Sep 2026 Carrie Russell VP of Accounting & Chief Accounting Officer Derivative Exercise and Retained +604 – 2,384
18 Aug 2026 Jill McConnell Officer Intent to Sell (Form 144) -4,892 $18.19 –
18 Aug 2026 Mark Morais COO & President of Clinical Services Intent to Sell (Form 144) -4,892 $18.19 –
18 Aug 2026 Mark Morais COO & President of Clinical Services Derivative Exercise and Sale -4,892 $18.19 82,411
17 Aug 2026 Mark Morais COO & President of Clinical Services Derivative Exercise and Retained +6,421 – 82,411
6 Aug 2026 Carrie Russell VP of Accounting & Chief Accounting Officer Initial Statement of Beneficial +0 – 15,325
5 Aug 2026 Anshul Thakral Chief Executive Officer Open Market Disposition -111,857 $18.17 204,940
4 Aug 2026 Anshul Thakral Chief Executive Officer Intent to Sell (Form 144) -99,869 $19.16 –
4 Aug 2026 Anshul Thakral Chief Executive Officer Derivative Exercise and Sale -99,869 $19.28 316,797
3 Aug 2026 Anshul Thakral Chief Executive Officer Derivative Exercise and Retained +316,797 – 316,797
2 Aug 2026 David Smith Independent Director Other Derivative Acquisition +15,840 – 28,692

From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.

Short interest, by report

Report dateShares short% of floatDays to cover
30 Oct 2026 8,571,804 8.9% 3.7
15 Oct 2026 7,675,846 8.1% 4.1
30 Sep 2026 12,564,688 13.2% 7.8
15 Sep 2026 12,550,566 13.2% 10.2
31 Aug 2026 11,937,000 12.6% 11.7
14 Aug 2026 11,501,125 12.1% 6.9

Discussion

No comments yet — be the first to weigh in on FTRE.

Sign in to join the discussion.

Scroll to Top